Legislative Research: NJ A5448 | 2022-2023 | Regular Session

Other Sessions

SessionTitle/DescriptionLast Action
2022-2023
Regular Session

(Introduced - Dead)
Classifies xylazine as Schedule III controlled dangerous substance under certain circumstances.
[A5448 2022 Detail][A5448 2022 Text][A5448 2022 Comments]
2023-05-11
Introduced, Referred to Assembly Judiciary Committee
2020-2021
Regular Session

(Introduced - Dead)
Requires commercial Internet websites and online services to notify consumers of collection and disclosure of personally identifiable information and allows consumers to opt out.
[A5448 2020 Detail][A5448 2020 Text][A5448 2020 Comments]
2021-03-08
Introduced, Referred to Assembly Science, Innovation and Technology Committee
2018-2019
Regular Session

(Introduced - Dead)
Bars the disclosure of personal identifying information of grand jury witnesses except for name; creates a fourth degree offense for attorney disclosure.
[A5448 2018 Detail][A5448 2018 Text][A5448 2018 Comments]
2019-05-23
Introduced, Referred to Assembly Judiciary Committee

References Online

Search PhraseWebNewsFinancialEncylopediaBiography
[New Jersey A5448]Google WebGoogle News
[New Jersey Assembly Judiciary Committee]Google WebGoogle NewsFollowTheMoney
[Representative Gerard Scharfenberger NJ]Google WebGoogle NewsFollowTheMoneyBallotpediaVoteSmart
[Representative Victoria Flynn NJ]Google WebGoogle NewsFollowTheMoneyBallotpediaVoteSmart

Legislative Citation

APA
NJ A5448 | 2022-2023 | Regular Session. (2023, May 11). LegiScan. Retrieved March 28, 2024, from https://legiscan.com/NJ/bill/A5448/2022
MLA
"NJ A5448 | 2022-2023 | Regular Session." LegiScan. LegiScan LLC, 11 May. 2023. Web. 28 Mar. 2024. <https://legiscan.com/NJ/bill/A5448/2022>.
Chicago
"NJ A5448 | 2022-2023 | Regular Session." May 11, 2023 LegiScan. Accessed March 28, 2024. https://legiscan.com/NJ/bill/A5448/2022.
Turabian
LegiScan. NJ A5448 | 2022-2023 | Regular Session. 11 May 2023. https://legiscan.com/NJ/bill/A5448/2022 (accessed March 28, 2024).

Subjects


Same As/Similar To

BillRelationshipDateTitleLast Action
A1526Carry Forward2024-01-09Classifies xylazine as Schedule III controlled dangerous substance under certain circumstances.Introduced, Referred to Assembly Judiciary Committee
S191Carry Forward2024-01-09Classifies xylazine as Schedule III controlled dangerous substance under certain circumstances.Introduced in the Senate, Referred to Senate Health, Human Services and Senior Citizens Committee
S3902Same As2023-06-01Classifies xylazine as Schedule III controlled dangerous substance under certain circumstances.Introduced in the Senate, Referred to Senate Health, Human Services and Senior Citizens Committee

New Jersey State Sources


feedback